AST and Marchesini Group Announce Strategic Partnership to Expand Global Market Presence
Partnership Combines Expertise and Technology to Accelerate Growth in Aseptic Manufacturing Tacoma, WA (USA) – December 9, 2025 – AST, a U.S leader in the
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer
Stephen to lead company-wide execution, strengthening AST’s Executive Leadership Team Tacoma, WA — August 6, 2025 — AST is pleased to announce that Jacob Stephen
AST Continues Its Commitment to U.S. Drug Product Manufacturing with Placement of Isolated Fill-Finish System with Bora Pharmaceuticals
The globally recognized CDMO selects an isolated GENiSYS® C to be placed in its Baltimore, Maryland, aseptic fill-finish facility. TACOMA Wash., May 29, 2025 —AST, a
AST Celebrates 60 Years of Excellence in Innovation and Looks to the Future of Drug Product Manufacturing
This milestone celebration sets the stage for AST’s next phase of strategic growth, anchored by its revitalized Mission, Vision, and Purpose statements TACOMA Wash., April
AST Welcomes Jason Rossi as Principal CQV Engineer
Rossi brings over 29 years of expertise and leadership in aseptic fill-finish and in the design, construction, commissioning, and qualification of pharmaceutical manufacturing systems and
AST Announces New Chief Commercial Officer, Charisse Curtis
AST expands its leadership team with a continued focus on growth and innovation within the life sciences industry. TACOMA Wash., March 17, 2025 —AST, a leading
AST Brings New ATMP Fill-Finish Production Line to INTERPHEX 2025
AST to introduce its fully automatic isolated GENiSYS C in addition to new glove testing and digital twin solutions during the premier global pharmaceutical event